A human B-lineage dendritic cell line, HBM-Noda and its potential role in human T-cell leukemia/lymphoma virus type I infection

Pathology International

Volumn 50, Issue 4, 2000, Pages 280-290

  Nagasaki, Makoto ^a   Morikawa, Shigeru ^a   Torii, Ikuko ^a   Zhang, Jie ^a   Morikawa, Keiko ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

Author keywords

Dendritic cell; Human B lineage dendritic cell line; Human T cell leukemia lymphoma virus type I infection

Indexed keywords

ANTIGEN P21; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION SENSITIVITY; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL LINEAGE; DENDRITIC CELLS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; VIRUS REPLICATION;

EID: 0033937851     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2000.01040.x     Document Type: Article

References (40)

1. 1 Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and presenting function of dendritic cells. Curr. Opin. Immunol. 1997; 9: 10-16.
2. 2 Austyn JM. Dendritic cells. Curr. Opin. Hematol. 1998; 5: 3-15.
3. 3 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
4. 4 Bhardwaj N. Interactions of viruses with dendritic cells: A double-edged sword. J. Exp. Med. 1997; 186: 795-799.
5. 5 Chesnut RW, Colon SM, Grey HM. Antigen presentation by normal B cells, B cell tumors, and macrophages: Functional and biochemical comparison. J. Immunol. 1982; 128: 1764-1768.
6. 6 Kurt-Jones EA, Liano D, HayGlass KA, Benacerraf B, Sy MS, Abbas AK. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J. Immunol. 1988; 140: 3773-3778.
7. + pro-B cells can give rise to dendritic cells in vitro. J. Immunol. 1998; 161: 5795-5799.
8. 8 Corradi MP, Jelinek DF, Ramberg JE, Lipsky PE. Development of a cell with dendritic morphology from a precursor of B lymphocyte lineage. J. Immunol. 1987; 138: 2075-2081.
9. 9 Nagasaki M, Senda N, Torii I, Morikawa S. NL26.2 Non-lineage antigens and dendritic cells functional studies: Two new monoclonal antibodies reactive with dendritic cells in the human tonsil In: Kishimoto T, Kikutani H, von dem Borne AEGK et al., eds. Leukocyte Typing VI. Garland Publishing Inc., New York, 1998; 592-593.
10. 10 Poiets BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA 1980; 77: 7415-7419.
11. 11 Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F, Takatsuki K. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 1984; 63: 1235-1240.
12. 12 Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy: A new clinical entity. Lancet 1986; 1: 1031-1032.
13. 13 De Revel T, Mabondzo A, Gras G et al. In vitro infection of human macrophages with human T-cell leukemia virus type 1. Blood 1993; 81: 1598-1606.
14. 14 Dhawan S, Streicher HZ, Wahl LM et al. Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection. J. Immunol. 1991; 147: 102-108.
15. 15 Fan N, Gavalchin J, Paul B, Wells KH, Lane MJ, Poiesz BJ. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J. Clin. Microbiol. 1992; 30: 905-910.
16. 16 Hoffman PM, Dhib-Jalbut S, Mikovits JA et al. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc. Natl Acad. Sci. USA 1992; 89: 11 784-11 788.
17. 17 Koralnik IJ, Lemp JF Jr, Gallo RC, Franchini G. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res. Human Retroviruses 1992; 8: 1845-1849.
18. 18 Koyanagi Y, Itoyama Y, Nakamura N et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993; 196: 25-33.
19. 19 Ali A, Patterson S, Cruickshank K, Rudge P, Dalgleish AG, Knight SC. Dendritic cells infected in vitro with human T cell leukemia/lymphoma virus type 1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin. Exp. Immunol. 1993; 94: 32-37.
20. 20 Fenoglio D, Li Pira G, Saverino D et al. Handling of retroviral antigens by human antigen-presenting cells. Res. Virol. 1996; 147: 97-101.
21. 21 Makino M, Shimokubo S, Wakamatsu S, Izumo S, Baba M. The role of human T-lymphotropic virus type 1 (HTLV-1) -infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 1999; 73: 4575-4581.
22. 22 Sundström C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 1976; 17: 565-577.
23. 23 Morikawa S, Harada T, Katoh T, Nagasaki M, Nakano H, Morikawa K. Heterogeneity of cellular origins in human malignant lymphoma cell lines derived from histio-monocytic lineage cells. In: Kano K, Mori S, Sugisaki T, Torisu M, eds. Cellular, Molecular and Genetic Approaches to Immunodiagnosis and Immunotherapy. University of Tokyo Press, Tokyo, 1987; 373-380.
24. 24 Nagasaki M, Harada T, Morikawa S. A new monoclonal antibody (1E8) reactive with dendritically shaped cells in the human tonsil. Pathol. Int. 1995; 45: 266-274.
25. 25 Nakano A, Morikawa S, Harada T. Ubiquitous expression of bcl-2 protein in mitotic nuclei and chromosomes. Acta Histochem. Cytochem. 1998; 31: 475-483.
26. 26 Zolla H, Bates D, Nobbs S. NL21. Non-lineage antigens blind panel: Flow cytometric analysis report In: Kishimoto T, Kikutani H, von dem Borne AEGK et al., eds. Leukocyte Typing VI. Garland Publishing, Inc., New York, 1998: 558-566.
27. 27 Katoh T, Harada T, Morikawa S, Wakutani T. IL-2-and IL-2-R-independent proliferation of T cell lines from adult T-cell leukemia/lymphoma patients. Int. J. Cancer 1986; 38: 265-274.
28. 28 Kuroda MJ, Kannagi M, Masuda T, Harada S. Inefficient transmission of HTLV-I to MOLT-4 cells by cell-free virus and cocultivation. Intervirology 1994; 34: 202-212.
29. 29 Kikuchi A, Ohata Y, Matsumoto H, Sugiura M, Nishikawa T. Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma. Cancer 1997; 79: 269-274.
30. 30 Hirai K, Hironaka T, Kawa-Ha K et al. Application of PCR to various clinical specimens for the detection of the Epstein-Barr virus and its evaluation. Rinsyo to Uirusu 1994; 4: 320-326 (in Japanese).
31. 1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl Acad. Sci. USA 1989; 86: 5620-5624.
32. 32 Markham PD, Salahuddin SZ, Kalyanaraman VS, Popovic M, Sarin P, Gallo RC. Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). Int. J. Cancer 1983; 31: 413-420.
33. 33 Miyoshi I, Kubonishi I, Yoshimoto S et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T cells. Nature 1981; 294: 770-771.
34. 34 Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988; 7: 519-523.
35. 35 Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl Acad Sci. USA 1988; 85: 9580-9584.
36. 36 Zucker-Franklin D, Fraig M, Grusky G. Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells. Clin. Diagn. Lab. Immunol. 1995; 2: 343-348.
37. 37 Gavalchin J, Fan N, Waterbury PG et al. Regional localization of putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology 1995; 212: 196-203.
38. 38 Tajima Y, Tashiro K, Camerini D. Assignment of the possible HTLV receptor gene to chromosome 17q21-q23. Somat. Cell Mol. Genet. 1997; 23: 225-227.
39. 39 Yang DW, Iwai H, Yamamoto A, Fu DX, Hoshino H. Effect of phospholipids on adsorption and penetration of human T cell leukemia virus type I. Biochim. Biophys. Acta 1997; 1349: 25-32.
40. 40 Salahuddin SZ, Ablashi DV, Hunter EA et al. HTLV-III infection of EBV-genome positive B-lymphoid cells with or without detectable T4 antigens. Int. J. Cancer 1987; 39: 198-202.